It has been approved in the US and other countries for the treatment of severe asthma, and regulatory reviews are ongoing in additional countries around the world.
Yet for some people with severe asthma, these drugs might not be enough to control symptoms. If you’re looking for something to supplement your drug treatment, you might want to try breathing ...
TNF-α may contribute to AHR, airway remodeling and GC resistance in asthma, thereby representing a potential target for therapy. Humanized murine anti-TNF mAb (infliximab) and a soluble TNF ...
More than 10% of Connecticut children and adults have asthma, which can be caused by allergic triggers or environmental ...
If you’re concerned about your mobility and asthma, talk with your doctor about the best treatment for you. What’s it like to use a wheelchair with asthma? Not everyone with severe asthma will ...
The European Commission has approved tezepelumab (Tezspire, AstraZeneca) as an add-on maintenance treatment for patients 12 years and older who have severe asthma that is inadequately controlled ...
A Canadian researcher says stem cells show promise as a potential treatment option for equine asthma, a condition previously known as heaves. Asthma can leave a horse struggling to breathe in ...
Matui found about 25 per cent (one in every four people) aged 12 and older did not receive treatment that best reduces their risk of future severe asthma attacks that could lead to hospitalisation ...
Each have respiratory problems, and two suffer from asthma. Cantley always carried around breathing treatment instructions and regularly went to the hospital for her children’s treatments.
The European Commission approved AstraZeneca Plc's (NASDAQ: AZN) Tezspire (tezepelumab) as an add-on maintenance treatment for severe asthma. The approval covers patients 12 years and above who ...